The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 03, 2019

Filed:

Oct. 12, 2016
Applicant:

HK Pharma, San Clemente, CA (US);

Inventors:

Jeffrey Alan Klein, San Juan Capistrano, CA (US);

Paytra Alan Klein, Newport Beach, CA (US);

Assignee:

HK TUMESCENT PHARMA CORPORATION, San Clemente, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 31/167 (2006.01); A61K 31/546 (2006.01); A61K 31/522 (2006.01); A61K 31/137 (2006.01); A61K 47/02 (2006.01); A61K 31/52 (2006.01); A61K 45/06 (2006.01); A61K 9/08 (2006.01); A61K 31/4164 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0019 (2013.01); A61K 31/137 (2013.01); A61K 31/167 (2013.01); A61K 31/52 (2013.01); A61K 31/522 (2013.01); A61K 31/546 (2013.01); A61K 47/02 (2013.01);
Abstract

Disclosed are methods of subcutaneous delivery of a drug or a therapeutic agent to a subject comprising administering to said subject a tumescent composition comprising: (a) the drug or the therapeutic agent, wherein a tumescent concentration of the drug is simultaneously: 1) below a threshold for local, subcutaneous tissue toxicity, 2) above a threshold for positive local therapeutic effect, and 3) above a concentration achievable by intravenous (IV), intramuscular (IM) or oral (PO) delivery; (b) a vasoconstrictor; and (c) a pharmaceutically acceptable carrier. Some embodiments relate to a method of treating or preventing sepsis or Systemic Inflammatory Response Syndrome (SIRS) in a subject. Some embodiments relate to a tumescent solution for treating a localized viral infection, e.g., varicella-zoster (shingles), the tumescent solution comprising an antiviral agent.


Find Patent Forward Citations

Loading…